BDTX
Companies
NASDAQ
Black Diamond Therapeutics, Inc.
Health Care
$2.48
+$0.34 (+15.89%)
Price Chart
Overview
About BDTX
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
Market Cap
$292.0M
Volume
6.1M
Avg. Volume
14.5M
P/E Ratio
-1.1065574
Dividend Yield
0.00%
Employees
67.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.64
High Correlation
Volatility
High (0.85)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, BDTX shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$292.0M
Volume6.1M
P/E Ratio-1.11
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 7, 2025Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025